Catalyst for a Cure Research Progress: Biomarker Initiative
Glaucoma Research Foundation established the Catalyst for a Cure Biomarker Initiative to help glaucoma patients preserve their vision.
Menu
Menu
Glaucoma Research Foundation established the Catalyst for a Cure Biomarker Initiative to help glaucoma patients preserve their vision.
“Two clinical trials are underway for vision restoration,” says Dr. Huberman. “These trials would not be possible without the identification of new biomarkers.”
There is evidence that the lens extraction and replacement method used for cataract treatment may be a viable option for primary closed-angle glaucoma as well.
Researchers are still in the early stages of exploring how this information can be turned into new glaucoma treatments.
“I am a researcher because I am driven to understand disease in order to treat it and be able to help people.”
– Tonia Rex, PhD
Dr. Goldberg talks about the Catalyst for a Biomarker Imitative and its impact on glaucoma research.
Dr. Goldberg’s research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, as well as stem cell and nanotherapeutic approaches to repair damaged eyes.
Researchers are working on some amazing things that artificial intelligence (AI) can do for glaucoma sufferers, especially in the areas of diagnosis and disease management, but it will take time and more work.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.